ResearcherActive in the last 2 years

Takefumi Onodera

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5153-7383; OpenAlex author ID A5091053912. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

TKTL1 mediates metabolic adaptation and stress resistance in pancreatic cancer cells under nutrient-deprived conditions. Co-author DOI 10.1038/s41388-026-03913-7 ↗
Human pancreatic cancer cells under nutrient deprivation are vulnerable to redox system inhibition. Co-author DOI 10.1074/jbc.ra120.013893 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Isao Momose · 2 shared papers, 2020–2026 · strength 0.51
- Paper TKTL1 mediates metabolic adaptation and stress resistance in pancreatic cancer cells under nutrient-deprived conditions. DOI 10.1038/s41388-026-03913-7 ↗
- Paper Human pancreatic cancer cells under nutrient deprivation are vulnerable to redox system inhibition. DOI 10.1074/jbc.ra120.013893 ↗
Manabu Kawada · 2 shared papers, 2020–2026 · strength 0.51
- Paper TKTL1 mediates metabolic adaptation and stress resistance in pancreatic cancer cells under nutrient-deprived conditions. DOI 10.1038/s41388-026-03913-7 ↗
- Paper Human pancreatic cancer cells under nutrient deprivation are vulnerable to redox system inhibition. DOI 10.1074/jbc.ra120.013893 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.